Just thinking simply if Neuren gets 70m USD from first sales milestone and sale of the priority voucher then announces a 30m USD up front payment for ROW deal that's $150m in Aussie dollars without any royalties. Assuming 20m in expenses for all the phase 2 trials on the go and 30% tax on the profit then you're looking at earnings over 90m so about 70c per share. At a conservative PE ratio of 30 that's over $20 per share. I don't know how the timing of these things play out and how quickly sales will come on but all I've put down here seems very doable to me as a low end before the next Annual report is due.
Just thinking simply if Neuren gets 70m USD from first sales...
-
- There are more pages in this discussion • 6,515 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |